Literature DB >> 25712964

Selection and Counterselection of Hia Expression Reveals a Key Role for Phase-Variable Expression of Hia in Infection Caused by Nontypeable Haemophilus influenzae.

John M Atack1, Linda E Winter2, Joseph A Jurcisek3, Lauren O Bakaletz3, Stephen J Barenkamp2, Michael P Jennings1.   

Abstract

Hia is a major adhesin of nontypeable Haemophilus influenzae (NTHi) and has long been investigated as a vaccine candidate. Here we show that Hia phase variation is controlled by changes in the length of a polythymidine tract located in the hia promoter. Studies of an invasive clinical isolate (strain R2866) show that strains expressing high Hia levels are more efficiently killed by opsonophagocytosis. An opsonophagocytic assay was used to select for a subpopulation of variants that expressed a low level of Hia, which facilitated their escape from killing by anti-Hia antisera. Conversely, a subpopulation of variants expressing a high level of Hia was selected for during passaging through Chang cells. In both cases, phase variation of Hia expression corresponded directly with discrete modal changes in polythymidine tract length. In the chinchilla model of NTHi infection, we observed consistent selection for high Hia expression upon nasopharyngeal colonization, confirming the key role of phase-variable expression of Hia within a specific niche in vivo.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Haemophilus; adhesion; colonization; phase variation

Mesh:

Substances:

Year:  2015        PMID: 25712964      PMCID: PMC4539897          DOI: 10.1093/infdis/jiv103

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children.

Authors:  Patricia Stutzmann Meier; Rolf Troller; Ioanna N Grivea; George A Syrogiannopoulos; Christoph Aebi
Journal:  Vaccine       Date:  2002-03-15       Impact factor: 3.641

2.  Genetic footprint on the ToxR-binding site in the promoter for cholera toxin.

Authors:  J D Pfau; R K Taylor
Journal:  Mol Microbiol       Date:  1996-04       Impact factor: 3.501

3.  Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae.

Authors:  J W St Geme; V V Kumar; D Cutter; S J Barenkamp
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.

Authors:  Laura A Novotny; John D Clements; Lauren O Bakaletz
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

5.  Adhesin genes and serum resistance in Haemophilus influenzae type f isolates.

Authors:  Michael E Watson; Kevin L Nelson; Victoria Nguyen; Carey-Ann D Burnham; Jill E Clarridge; Xuan Qin; Arnold L Smith
Journal:  J Med Microbiol       Date:  2012-12-14       Impact factor: 2.472

Review 6.  Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention.

Authors:  Lauren O Bakaletz
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

Review 7.  Otitis media: prospects for prevention.

Authors:  Mark Haggard
Journal:  Vaccine       Date:  2008-12-23       Impact factor: 3.641

8.  A virulent nonencapsulated Haemophilus influenzae.

Authors:  V Nizet; K F Colina; J R Almquist; C E Rubens; A L Smith
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

9.  A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements.

Authors:  Matteo M E Metruccio; Eva Pigozzi; Davide Roncarati; Francesco Berlanda Scorza; Nathalie Norais; Stuart A Hill; Vincenzo Scarlato; Isabel Delany
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

Review 10.  Structure and function of the Haemophilus influenzae autotransporters.

Authors:  Nicole A Spahich; Joseph W St Geme
Journal:  Front Cell Infect Microbiol       Date:  2011-09-28       Impact factor: 5.293

View more
  20 in total

1.  Discovery and Contribution of Nontypeable Haemophilus influenzae NTHI1441 to Human Respiratory Epithelial Cell Invasion.

Authors:  C P Ahearn; C Kirkham; L D Chaves; Y Kong; M M Pettigrew; T F Murphy
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 2.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

3.  Naturally Acquired HMW1- and HMW2-Specific Serum Antibodies in Adults and Children Mediate Opsonophagocytic Killing of Nontypeable Haemophilus influenzae.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2015-10-28

4.  Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae.

Authors:  Laura A Novotny; Kenneth L Brockman; Elaine M Mokrzan; Joseph A Jurcisek; Lauren O Bakaletz
Journal:  J Pediatr Infect Dis       Date:  2018-07-06       Impact factor: 0.293

5.  The modA10 phasevarion of nontypeable Haemophilus influenzae R2866 regulates multiple virulence-associated traits.

Authors:  Timothy M VanWagoner; John M Atack; Kevin L Nelson; Hannah K Smith; Kate L Fox; Michael P Jennings; Terrence L Stull; Arnold L Smith
Journal:  Microb Pathog       Date:  2015-12-21       Impact factor: 3.738

6.  Why we need a vaccine for non-typeable Haemophilus influenzae.

Authors:  Marina Cerquetti; Maria Giufrè
Journal:  Hum Vaccin Immunother       Date:  2016-05-12       Impact factor: 3.452

Review 7.  Phasevarions of Bacterial Pathogens: Methylomics Sheds New Light on Old Enemies.

Authors:  John M Atack; Aimee Tan; Lauren O Bakaletz; Michael P Jennings; Kate L Seib
Journal:  Trends Microbiol       Date:  2018-02-13       Impact factor: 17.079

8.  Systematic Analysis of REBASE Identifies Numerous Type I Restriction-Modification Systems with Duplicated, Distinct hsdS Specificity Genes That Can Switch System Specificity by Recombination.

Authors:  John M Atack; Chengying Guo; Thomas Litfin; Long Yang; Patrick J Blackall; Yaoqi Zhou; Michael P Jennings
Journal:  mSystems       Date:  2020-07-28       Impact factor: 6.496

9.  A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae.

Authors:  John M Atack; Yogitha N Srikhanta; Kate L Fox; Joseph A Jurcisek; Kenneth L Brockman; Tyson A Clark; Matthew Boitano; Peter M Power; Freda E-C Jen; Alastair G McEwan; Sean M Grimmond; Arnold L Smith; Stephen J Barenkamp; Jonas Korlach; Lauren O Bakaletz; Michael P Jennings
Journal:  Nat Commun       Date:  2015-07-28       Impact factor: 14.919

10.  A survey of Type III restriction-modification systems reveals numerous, novel epigenetic regulators controlling phase-variable regulons; phasevarions.

Authors:  John M Atack; Yuedong Yang; Kate L Seib; Yaoqi Zhou; Michael P Jennings
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.